167 items found, showing page 3 of 14
Helping deliver Scotland’s vision for healthcare and drawing on rich pool of Scottish talent
Industry-led initiative agrees key actions to increase turnover to £900m by 2025
Scottish Development International welcomes findings from the latest Global Connections Survey which reveal that Scottish exports have increased by 7.2% to reach a record £27.9 billion.
Scottish Enterprise has today announced the shortlist of finalists for its 2015 Life Sciences Awards.
Scottish Biopharmaceutical Company MGB Biopharma Secures £4.0m ($6.4m) to Develop New Antibacterial Drug against the Major Global Problem of Antimicrobial Resistance
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, announces today that it has secured £4.0m ($6.4m) to advance the development of its lead antibacterial, MGB-BP-3, against a range of Gram-positive infections including Clostridium difficile and methicillin-resistant and susceptible Staphylococcus species. MGB-BP-3 is the first novel class of antibacterial for over a decade with a new mode of action to be developed globally. The drug - originally developed at the University of Strathclyde and licensed to MGB Biopharma - could make a real difference in the fight against antimicrobial resistance.